Fiscal year 24 tick-borne disease research program
Ended Awarded Last action
- Contract number
- HT942524F0103
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $159,828
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 82% obligated
- $195,200.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chantilly, VA 20151, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Funding Only Action | -$35,373 | |
| Funding Only Action | $97,408 | |
| Funding Only Action | -$580 | |
| Original award | $98,372 |
About this award
The Defense Health Agency awarded a delivery order valued at $195,200.92 to Leidos, Inc. (through its Leidos Services Operating Segment division, doing business as SAIC) on June 10, 2024, for support of the Fiscal Year 24 Tick-Borne Disease Research Program. This cost-plus-fixed-fee contract, with an ultimate completion date of June 9, 2025, supports the agency's mission to address tick-borne diseases as a threat to military forces and their dependents. The work will be performed in Chantilly, Virginia, and no small business set-aside designation was utilized for this award.
Leidos, Inc., a large global technology and engineering solutions provider headquartered in Reston, Virginia, brings substantial experience in medical research support across the federal government. As a subsidiary of Leidos Holdings, Inc., the awardee has previously secured numerous contracts with the Defense Health Agency and other health-focused agencies supporting research in areas including infectious diseases, psychological health, and other medical conditions. The tick-borne disease research program aligns with Leidos' established capabilities in supporting complex scientific research initiatives for the Department of Defense and its related agencies.
Quick answers
Who was awarded contract HT942524F0103?
HT942524F0103 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on June 10, 2024.
How much is contract HT942524F0103 worth?
The government has obligated $159,828 on HT942524F0103. Its current value, with exercised options, is $195,201.
Is contract HT942524F0103 an order under another contract?
Yes. HT942524F0103 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942524F0103 competed?
The extent of competition for HT942524F0103 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award